XJPX6034
Market cap26mUSD
Jan 09, Last price
749.00JPY
1D
5.34%
1Q
-8.21%
Jan 2017
-57.54%
IPO
-47.62%
Name
MRT Inc
Chart & Performance
Profile
MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling, and online medical care; Pocket Doctor, a telemedicine/health consultation app; groupware for medical offices; FASTCALL that consolidates the functions required for hospital crisis management system as safety confirmation service for medical institution; and Good Doctors, which provides owned media sent by doctors. It also offers nurse and pharmacist recruitment service; human resources introduction service for clinical laboratory engineers, radiologists, and dialysis nurses, as well as for new business openings and succession projects; and recruitment information service for exclusive industrial physicians and contract industrial physicians. In addition, the company engages in employment agency business, opening of business, business succession support business, and PR business, and career support business. Further, it offers services for supporting the operation of medical institutions, such as fund management, utilizing medical fee factoring, payroll calculation for doctors' part-time jobs, and payroll transfer agency services. Additionally, the company sells human umbilical cord-derived stem cell culture supernatant; and provides babysitter services, tax accountant referral service, credit card payment agency service, questionnaire survey request for pharmaceuticals, etc., as well as media coverage cooperation, lecture request, event rescue, etc. It also publishes books on illness and treatment; and offers health maintenance service and member comprehensive compensation systems. The company was formerly known as Medical Research and Technology Co., Ltd and changed its name to MRT Inc. in September 2014. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | |||||
Revenues | 5,407,087 -38.12% | 8,738,193 95.52% | |||
Cost of revenue | 4,440,219 | 5,762,495 | |||
Unusual Expense (Income) | |||||
NOPBT | 966,868 | 2,975,698 | |||
NOPBT Margin | 17.88% | 34.05% | |||
Operating Taxes | 319,349 | 754,043 | |||
Tax Rate | 33.03% | 25.34% | |||
NOPAT | 647,519 | 2,221,655 | |||
Net income | 517,000 -76.06% | 2,159,994 178.89% | |||
Dividends | (164,000) | ||||
Dividend yield | 3.21% | ||||
Proceeds from repurchase of equity | (168,000) | 35 | |||
BB yield | 3.29% | 0.00% | |||
Debt | |||||
Debt current | 513,000 | 638,056 | |||
Long-term debt | 294,000 | 422,318 | |||
Deferred revenue | (66,469) | ||||
Other long-term liabilities | 253,000 | 236,273 | |||
Net debt | (3,411,000) | (4,101,345) | |||
Cash flow | |||||
Cash from operating activities | (193,584) | 4,511,679 | |||
CAPEX | (15,000) | (80,508) | |||
Cash from investing activities | (243,608) | (431,114) | |||
Cash from financing activities | (669,192) | (203,982) | |||
FCF | 343,514 | 3,487,439 | |||
Balance | |||||
Cash | 3,783,000 | 4,897,583 | |||
Long term investments | 435,000 | 264,136 | |||
Excess cash | 3,947,646 | 4,724,809 | |||
Stockholders' equity | 4,660,000 | 4,438,012 | |||
Invested Capital | 1,661,354 | 469,969 | |||
ROIC | 60.76% | 185.56% | |||
ROCE | 17.24% | 59.82% | |||
EV | |||||
Common stock shares outstanding | 5,480 | 5,578 | |||
Price | 931.00 -43.16% | 1,638.00 16.42% | |||
Market cap | 5,101,781 -44.17% | 9,137,303 16.38% | |||
EV | 1,827,781 | 5,306,008 | |||
EBITDA | 1,195,221 | 3,160,576 | |||
EV/EBITDA | 1.53 | 1.68 | |||
Interest | 42,265 | ||||
Interest/NOPBT | 1.42% |